Aadi Bioscience appoints Brendan Delaney as COO effective Sept 20, 2021

Whitehawk Therapeutics, Inc.

Delaney previously Chief Commercial Officer at Constellation Pharmaceuticals (acquired by MorphoSys for $1.4B) and Immunomedics.
Annual base salary of $480,000, target bonus of 45%, and option to purchase 260,000 shares vesting over 4 years.
Severance includes 12 months base salary plus COBRA reimbursement; full acceleration of equity upon change-in-control termination.
Company highlights upcoming PDUFA date of Nov 26, 2021 for ABI-009 in PEComa and plans to initiate registrational trial for TSC1/TSC2 alterations.
Delaney will establish Aadi's East Coast presence; has prior roles at Celgene/BMS and Novartis.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brendan Delaney

Chief Operating Officer

WHWK · Whitehawk Therapeutics, Inc.

Effective: 2021-09-20
Filed: September 20, 2021, 7:59 PM ET

On September 19, 2021, Aadi Bioscience, Inc. (the “ Company ”) appointed Brendan Delaney as the Company’s Chief Operating Officer, effective September 20, 2021

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brendan Delaney was appointed as Chief Operating Officer at Whitehawk Therapeutics, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On September 19, 2021, Aadi Bioscience, Inc. (the “ Company ”) appointed Brendan Delaney as the Company’s Chief Operating Officer, effective September 20, 2021

View on SEC.gov

Whitehawk Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-276826

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.